2022. Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose. Clinics. 78, (Nov. 2022), 100150. DOI:https://doi.org/10.1016/j.clinsp.2022.100150.